NEURIM PHARMACEUTICALS (1991) LTD v GENERICS UK LTD (T/A MYLAN)

Reports of Patent, Design and Trade Mark Cases Pub Date : 2021-04-01 DOI:10.1093/rpc/rcac004

引用次数: 0

Abstract

H1 Patents — European patents — Pharmaceuticals — Interim injunctions — Proposed generic launch — Expedited trial — Assessment of adequacy of damages — Balance of convenience — Clearing the path — Appeal to Court of Appeal

查看原文本刊更多论文

NEURIM PHARMACEUTICALS (1991) LTD诉GENERICS UK LTD (T/A MYLAN)

H1专利-欧洲专利-药品-临时禁令-拟议的仿制药上市-加速审判-损害赔偿充分性评估-便利平衡-扫清道路-上诉法院

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Reports of Patent, Design and Trade Mark Cases

自引率

0.00%

发文量